✦ LIBER ✦

O7 An exploratory analysis of the impact of age, performance status, and comorbidity on clinical outcomes in a randomized phase II trial of single agent gemcitabine, vinorelbine or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly

✍ Scribed by Ngeow, J.; Poon, D.; Leong, S.S.; Gao, F.; Toh, C.K.; Lim, W.T.; Xu, L.; Tan, S.B.; Tay, M.H.; Foo, K.F.; Ho, J.; Tan, E.H.

Book ID: 122088436
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 58 KB
Volume: 60
Category: Article
ISSN: 1040-8428
DOI: 10.1016/S1040-8428(13)70064-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-53 A randomized phase II trial of gemc

O-53 A randomized phase II trial of gemcitabine, vinorelbine or docetaxel in the treatment of elderly and/or poor performance state patients with non-small cell lung cance (NSCLC)

✍ Leong, Swan Swan; Fool, Kian Fong; Tay, Miah Hiang; Toh, Chee Keong; Lim, Darren 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Randomized phase II trial of gefitinib o

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB

An open multicenter phase II trial of we

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study

✍ LECAER, H; BARLESI, F; ROBINET, G; FOURNEL, P; GERINIERE, L; BOMBARON, P; FALCHE 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Weekly docetaxel versus docetaxel/gemcit

Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer : A randomized phase 3 trial of the Minnie Pearl Cancer Research Network

✍ John D. Hainsworth; David R. Spigel; Cindy Farley; Dianna L. Shipley; James D. B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract ## BACKGROUND. The aim of this study was to compare the efficacy of single‐agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Previously untreated pat

PD-068 An exploratory analysis of a phas

PD-068 An exploratory analysis of a phase III study in patients with advanced non-small cell lung cancer (NSCLC): The impact of first-line gemcitabine and platinum therapy on the outcome of second-line therapy with pemetrexed or docetaxel

✍ Bunn, P.; Rosell, R.; Fossella, F.; Perry, M.; Stahel, R.; Barata, F.; Nguyen, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB